|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
AcuNetx (ANTX) Files 10KSB Showing Continued Improvement & Growth
4/1/2008 8:44:09 AM
TORRANCE, Calif.--(BUSINESS WIRE)--AcuNetx, Inc. (OTCBB:ANTX - News), announced today that it has filed its year ending December 31, 2007 10KSB. Unit sales of its products increased 35% from 2006 with overall gross profit improving from $1,608,796 in 2006 to $1,960,627 in 2007. The expenditure controls put into place in early 2007 resulted in an 89% decrease in the company’s net loss, from $8,223,391 in 2006 to $905,070 in 2007. Selling, general and administrative expenses also significantly decreased by 37%, from $4,062,300 in 2006 to $2,586,411 in 2007. Another important business metric was year-end net accounts receivable which decreased 84% from the prior year.
|
|
|
|
|
|
|
|
|
|
|